Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
FlowMetric Life Sciences Inc. Introduces the Breakthrough VaxEffect™ COVID-19 Vaccine Immune Response Test
Wednesday, July 14, 2021FlowMetric Life Sciences Inc a globally recognized life sciences company announces the launch of VaxEffect COVID Vaccine Immune Response Test a unique and powerful platform exclusively created to quantitatively assess and track now and over time an i...
Kintor Pharmaceutical Receives IND Clearance by the U.S. FDA for GT20029 to Treat Androgenetic Alopecia and Acne
Wednesday, July 14, 2021Kintor Pharmaceutical Limited a clinicalstage biotechnology company developing innovative smallmolecule and biological therapeutics today announced that the US Food and Drug Administration FDA has cleared an Investigational New Drug IND application f...
Prothena and Novo Nordisk announce acquisition agreement for Prothena’s ATTR amyloidosis programme
Tuesday, July 13, 2021Prothena Corporation plc and Novo Nordisk AS today announced that the companies have entered into a definitive purchase agreement under which Novo Nordisk has acquired Prothenas clinical stage antibody PRX and broader ATTR amyloidosis programme PRX i...
Biogen and Innocare Announce License and Collaboration Agreement For Orelabrutinib, an Innovative CNS Penetrant BTK Inhibitor For the Potential Treatment of Multiple Sclerosis
Tuesday, July 13, 2021Biogen Inc and InnoCare Pharma Limited announced that they have entered into a license and collaboration agreement for orelabrutinib an oral small molecule Brutons tyrosine kinase inhibitor BTKi for the potential treatment of multiple sclerosis MS Or...
Everest Medicines Announces Strategic Commercial Partnership with Global Technology Company, Tencent
Monday, July 12, 2021Everest Medicines a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Greater China and other parts of Asia today announced that it has...
Chugai and Alebund Enter into Option and License Agreement for EOS789 under Development for Hyperphosphatemia
Saturday, July 10, 2021Chugai Pharmaceutical Co Ltd and Alebund Pharmaceuticals Hong Kong Limited announced that they have entered into an option and license agreement regarding Chugais EOS an investigational agent under development for hyperphosphatemia EOS is an oral inh...
Merck and Inbrain Neuroelectronics Collaborate to Develop the Next Generation of Bioelectronic Therapies
Friday, July 09, 2021Merck a leading science and technology company today announced a second collaboration agreement in its Bioelectronics innovation field with Innervia Bioelectronics a startup and subsidiary of Inbrain Neuroelectronics SL Barcelona Spain The aim of the...
Vor Biopharma Announces Collaboration with Janssen to Develop Engineered Hematopoietic Stem Cell Transplants Combined With a Bi-Specific Antibody Therapy for Acute Myeloid Leukemia (AML)
Friday, July 09, 2021Vor Biopharma Nasdaq VOR or the Company a cell therapy company pioneering engineered hematopoietic stem cell eHSC therapies combined with targeted therapies for the treatment of cancer today announced the formation of a collaboration with Janssen Bio...
Toxicology IND Preclinical Research Services by Altogen Labs CRO
Tuesday, July 06, 2021Altogen Labs a preclinical CRO provides essential safety and efficacy testing for novel medicines GLPcompliant pharmtox assays per FDA IND requirements Company works with renowned academic research organizations and pharmabiotech industry to reduce G...
Everest Medicines Announces that Spero Therapeutics Entered into Licensing Agreement with Pfizer Inc. for SPR206 in ex-U.S. and ex-Asia Territories
Monday, July 05, 2021Everest Medicines a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products for patients in Greater China and other parts of Asia today announced that Spero Therapeutics Inc Nasdaq SPRO a licensing p...
